Liu Jinping, Chang Lirong, Song Yizhi, Li Hui, Wu Yan
School of Medicine, Tsinghua University, Beijing, China.
Department of Anatomy, Ministry of Science and Technology Laboratory of Brain Disorders, Beijing Institute for Brain Disorders, Capital Medical University, Beijing, China.
Front Neurosci. 2019 Feb 8;13:43. doi: 10.3389/fnins.2019.00043. eCollection 2019.
In Alzheimer's disease (AD), early synaptic dysfunction is associated with the increased oligomeric amyloid-beta peptide, which causes NMDAR-dependent synaptic depression and spine elimination. Memantine, low-affinity NMDAR channel blocker, has been used in the treatment of moderate to severe AD. However, clear evidence is still deficient in demonstrating the underlying mechanisms and a relationship between NMDARs dysfunction and AD. This review focuses on not only changes in expression of different NMDAR subunits, but also some unconventional modes of NMDAR action.
在阿尔茨海默病(AD)中,早期突触功能障碍与寡聚淀粉样β肽增加有关,该肽会导致NMDAR依赖的突触抑制和树突棘消除。美金刚是一种低亲和力的NMDAR通道阻滞剂,已用于治疗中度至重度AD。然而,在证明其潜在机制以及NMDAR功能障碍与AD之间的关系方面,仍缺乏明确的证据。本综述不仅关注不同NMDAR亚基表达的变化,还关注NMDAR作用的一些非常规模式。
Front Neurosci. 2019-2-8
Acta Neuropathol Commun. 2018-10-23
J Alzheimers Dis. 2017
Neuropharmacology. 2013-8-22
Mol Neurodegener. 2014-11-14
J Neurosci. 2017-10-4
Front Neural Circuits. 2025-7-29
MedComm (2020). 2025-6-25
Front Aging Neurosci. 2025-5-30
Acta Neuropathol. 2018-10-22
Nat Rev Neurosci. 2018-11
Eur J Clin Invest. 2018-10-4
Structure. 2018-6-7
Nature. 2018-4-18